Illumina Inc (ILMN)
NASDAQ · Manufacturing · Laboratory analytical instruments
$267.77−$6.13 (−2.24%) on the dayAs of the close; data may be delayed.
ILMN price, last 12 months
Key stats
- Previous close
- $273.90
- Open
- $274.74
- Day range
- $267.66 – $276.97
- 52-week range
- $88.00 – $277.95
- Volume
- 4.5M
- Avg volume (20 days)
- 3.9M
- Market cap
- $40.8B
Performance
1W+11.8%
1M+19.1%
3M+51.7%
6M+115.3%
YTD+104.2%
1Y+183.6%
vs S&P 500, 1Y+166.8 pts
Technicals and fundamentals
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
- Sector
- Manufacturing
- Industry
- Laboratory analytical instruments
- Listed on
- NASDAQ
- Market cap
- $40.8B